SEC Form D private-offering filing

Embold Therapeutics, Inc.

A new SEC Form D private-offering notice from Redwood City, CA, a $500,000 filer-stated offering target in Biotech. The source filing is one click away.

Embold Therapeutics, Inc. site↗ Verified via SEC Form D

Redwood City California biotechnology company developing AI driven, CNS delivered precision therapeutics for Parkinson's disease that target the GBA1 and glucocerebrosidase pathway.

Filed 2026-02-09Filed to raise $500,000First money in 2026-01-21Raised so far $500,000HQ (as filed) Redwood City, CASector Biotech ✓Stage (inferred) Pre-seedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified emboldtx.com↗Named in the filing 1 executive & director
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Also filed for this raise

every source Form D behind this opportunity
  • Embold Therapeutics, Inc., 2026-02-09, $500K EDGAR↗
  • Embold Therapeutics, Inc., 2026-02-09, $3M EDGAR↗